1. brianpitkin
2. reformed4553
3. edesedyjy69fed
4. andersenj182
5. mlaura
1.brianpitkin 01/26/2018
Company announced that new interim results from its ongoing Phase 1 clinical trial of MRG-106 in patients wi…
2.edesedyjy69fed 02/05/2018
perfect day for it, everything is dying
3.brianpitkin 02/05/2018
miRagen Therapeutics Announces Proposed Public Offering of Common Stock
4.edesedyjy69fed 02/08/2018
Prices 7 mln share common stock offering at $5.50 per share
5.reformed4553 02/05/2018
6.edesedyjy69fed 02/02/2018
Nice News out - miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell Lymphoma Forum
7.brianpitkin 04/27/2018
miRagen Therapeutics Announces New Data Showing Administration of MRG-110 Improved Tissue Perfusion and Wound Healing in Late Stage Preclinical Studies
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW